Holen Sie sich die Stockscreener-App
1.13
8.87%
-0.11
Handel nachbörslich:
1.14
0.01
+0.88%
Schlusskurs vom Vortag:
$1.24
Offen:
$1.22
24-Stunden-Volumen:
461.97K
Relative Volume:
16.21
Marktkapitalisierung:
$28.74M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-12.40%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.1208
$1.2438
1-Wochen-Bereich:
$1.1208
$1.39
52-Wochen-Spanne:
$1.1208
$1.39
Lunai Bioworks Inc Stock (LNAI) Company Profile
Firmenname
Lunai Bioworks Inc
Sektor
Branche
Telefon
45 39179840
Adresse
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Vergleichen Sie LNAI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNAI
Lunai Bioworks Inc
|
1.13 | 28.74M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lunai Bioworks Inc Aktie (LNAI) Neueste Nachrichten
Lunai Bioworks reports 35% improvement in Alzheimer’s diagnostics - Investing.com
Lunai Bioworks Launches AI-Powered Alzheimer's Disease Program, Expanding Neurodegenerative Pipeline - PharmiWeb.com
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - Online Athens
Seven new option listings and two option delistings on October 1st - TipRanks
LNAI Stock Price and Chart — NASDAQ:LNAI - TradingView
Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on - PharmiWeb.com
AI Drug Discovery Pioneer Lunai Bioworks Emerges with New Identity and Streamlined 23.2M Share Structure - Stock Titan
Analyzing Climb Bio (NASDAQ:CLYM) & Lunai Bioworks (NASDAQ:RENB) - Defense World
Renovaro Biosciences Announces Reverse Stock Split - TipRanks
Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split - PharmiWeb.com
Lunai Bioworks to effect 10:1 reverse stock split - MSN
Lunai Bioworks stock plunges after announcing 10:1 reverse split By Investing.com - Investing.com UK
$1.85M NIH Grant Powers Lunai Bioworks' AI Platform to Combat Alcohol Disorder Affecting 19M Americans - Stock Titan
Top 3 Health Care Stocks You'll Regret Missing In Q3 - Sahm
Lunai Bioworks launches transformer-base platform to secure GenAI - Yahoo Finance
Lunai Bioworks (RENB) Restructures European Operations for Strat - GuruFocus
AI Drug Discovery Firm Lunai Bioworks Restructures European Business, Maintains Growth Strategy - Stock Titan
Renovaro Biosciences Faces Subsidiary Bankruptcy Impact - TipRanks
Lunai Bioworks Inc. Retains American Defense International - PharmiWeb.com
User - FinancialContent
Renovaro Inc. changes corporate name to Lunai Bioworks Inc., maintains Nasdaq symbol - Investing.com
Merger Crisis: Renovaro Threatens Legal Action After Predictive Oncology Backs Out - Stock Titan
RENBRenovaro Latest Stock News & Market Updates - Stock Titan
Enochian Biosciences Is A House Of CardsThe Pipeline Is Entirely Pre-Clinical And Management Has A Questionable History (NASDAQ:RENB) - Seeking Alpha
Finanzdaten der Lunai Bioworks Inc-Aktie (LNAI)
Es liegen keine Finanzdaten für Lunai Bioworks Inc (LNAI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):